The Western blotting analysis (HCT116 cell lines) (Fig 4D) results indicated that exposure to arctigenin for 48 h significantly reduced the expressions of MMP-2 and MMP-9 in CRC cells, and this inhibition of MMP-2 and MMP-9 proteins was dose-dependent. The gene discussed is MMP9; the disease is colorectal carcinoma.